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The detectability of breast cancer by screening mammography
S Ciatto, M Rosselli Del Turco and M Zappa
Centro per lo Studio e la Prevenzione Oncologica, Viale A. Volta 171, I-50131 Florence, Italy.
Summary We reviewed 134 patients with breast cancer (screen detected = 85, interval = 49) who had been
reported as negative at previous mammographic screening in the Florence District Programme. At prior
mammograms review, 12% of the cases were classified as 'screening error' (suspicious signs missed owing to
misperception or poor imaging technique), 26% as 'minimal signs present', 54% as 'radiographically occult'
and 7% as 'radiographically occult at diagnosis'. These results are quite consistent with those recently reported
for the Nijmegen screening programme. Screening errors may be reduced either by reducing the risk of
misperception (double reading) or by improving imaging quality, but this would achieve earlier detection in a
minority of cancer cases. Minimal signs of cancer were present 2 years before the diagnosis in over one-third
of screen-detected cancers. Increasing screening frequency (from biennial to annual) may advance detection
time of most 'screening errors' and of some cancers in the 'minimal signs present' and 'mammographically
occult' categories, but this would almost double screening costs, and the benefit would probably be inferior to
that obtained by doubling the population invited to biennial screening. Adopting less stringent criteria for
referral to diagnostic assessment would probably lead to the detection of some cases in the 'minimal signs
present' category. This seems to us a more convenient policy to adopt to advance cancer detection time,
although it will also sharply increase referral rates and costs. As diagnostic assessment of minimal lesions is far
from being 100% accurate, this policy would also considerably increase the frequency of unnecessary benign
biopsies. All these negative effects might turn out to be unacceptable.
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When evaluating the performance of mammographic screen-
ing, interval cancers are currently assumed to be errors (false
negatives) of the screening programme, whereas screen-
detected cancers are assumed to be true positives.
Review of previous screening mammograms allows the
reasons for missed diagnosis of interval cancers to be
analysed. In approximately 50% of interval cases, at least
minimal signs of cancer are evident on the previous screening
mammogram (Martin et al., 1979; Von Rosen et al., 1985;
Frisell et al., 1987; Peeters et al., 1989), and shortening the
rescreening interval from 2 to 1 years has been suggested to
advance the time of detection of interval cancers.
In a recent report, Van Dijck et al. (1993) extended this
analysis to screen-detected cancers, and the review of
previous screening mammograms revealed at least minimal
signs of cancer in over 50% of cases.
In the study presented here, we review the previous screen-
ing mammograms of a consecutive series of both interval and
screen-detected cancers observed in the Florence District
Screening Programme, in order to compare with the findings
of Van Dijck et al. The implications of these findings on the
criteria adopted for reporting screening mammography and
on the choice of the optimal rescreening interval are then
discussed.
Material and methods
A population-based screening programme has been ongoing
in the District of Florence since 1970. The features of the
programme, as well as an estimate of its efficacy by means of
a case-control study, have been reported previously (Palli et
al., 1986; Paci et al., 1990).
In the present study we reviewed all screen-detected and
interval cancers occurring in women who had had a previous
negative screening mammogram in the years 1987-90. As we
adopted a biennial rescreening interval, screen-detected
cancers eligible for the study were diagnosed between 1989
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and 1992. Interval cancers were defined as those diagnosed at
our centre or surfacing in the local cancer registry (Geddes et
al., 1991) in the 2 year interval between two consecutive
screening rounds and reported as negative at the previous
screening mammogram. Interval cancers eligible for the study
were diagnosed between 1987 and 1991, as no data are yet
available from the cancer registry for the year 1992. The rate
of interval cancers has been previously reported (Paci et al.,
1990): the observed interval/expected incident cancer ratio for
the first or second year of the interval was 0.24 or 0.41 in the
40-49, 0.17 or 0.45 in the 50-59 and 0.09 or 0.17 in the
60-69 years age group respectively.
The previous negative screening mammograms and the
diagnostic mammograms were reviewed by one of us (SC)
having knowledge of the site and the features of cancer at
diagnosis, and were classified into four categories according
to the criteria specified by Van Dijck et al. (1993).
Screening error. (a) Suspicious signs evident at review,
which had not been perceived or had been misdiagnosed as
benign; (b) lesion not encompassed in the mammographic
field owing to incorrect breast positioning; or (c) lesion not
perceptible owing to poor technical quality.
Minimal signs present. Evidence of minor abnormalities,
which could be ascribed to the presence of cancer at the time
of review, but were judged to be non-specific and did not
reach the threshold of suspicion.
Radiographically occult. No abnormalities could be seen on
the previous screening mammogram at the cancer site.
Radiographically occult at diagnosis. No abnormalities
could be seen on both the diagnostic and the previous screen-
ing mammogram.
Other data available from screening records for each
patient were the date and age at diagnosis, the date of
previous screening mammogram, histological diagnosis, pT
and pN pTNM categories, Wolfe's parenchymal pattern and
radiographic appearance of cancer at diagnosis (opacity with
sharp, poorly defined or stellate margins, isolated
calcifications, parenchymal distortion).
We studied the association of different variables to the
review of previous screening mammograms, and compared
these results with those observed by Van Dijck et al.
(1993).ascanmr domob S by mam msapqk
Results
Overall. 134 patients were eligible for the study, 85 being
screen detected and 49 being detected in the rescreening
interval (22 in the first; 27 in the second year). Table I shows
the distribution of screen-detected and interval cancers by
different variables. Interval cancers occurred in younger
women, were larger and had a higher frequency of involved




40-49 1 1 16
50-59 29 13
60-69 45 20
Tumour size at diagnosis' (mm)
<10 29 4




Not involved 67 26
Histological type
Intraductal 7 2
Ductal invasive 30 25
Lobular invasive 14 7
Other 34 15
'Invasive casesonly; not available for one interval case. bInvasive cases
only; not determined for three cases.
nodes. No differences were recorded in histological subtype
or oestrogen receptor content, the latter being determined
only in a minority of cases (30 screen-detected, 24 interval
cancers). Histological grading was not available as it is not
currently specified in the pathological report.
Table II shows the distribution of cases according to the
review of previous screening mammograms and according to
the other variables studied. Twelve per cent of the cases were
classified as 'screening errors'. 26% as 'minimal signs pre-
sent', 54% as 'radiographically occult' and 7% as 'radio-
graphically occult at diagnosis'.
Screening error was reported in 16 cases, being more fre-
quent among interval than screen-detected cases (22% vs
6%). Technical errors were recorded in five cases, owing to
poor positioning in four cases (interval =2) and to poor
imaging quality in one (interval) case, whereas mammo-
graphic abnormalities had not been perceived in the remain-
ing 11 cases (interval = 8). Opacities with irregular or stellate
margins were recorded in most cases (88%) at diagnosis. All
cancers were invasive and larger than those in other
categories.
Minimal signs were observed on the previous screening
mammogram in 35 cases, mostly (31 of 35) in screen-detected
cancers. Isolated microcalcifications were more frequently
recorded at diagnosis compared with other categories (34%
vs 18%), and pT and pN distribution was moderately less
favourable than in mammographically occult cases.
At review of the previous screening mammogram, no
mammographic abnormality was found at the cancer site in
73 cases classified as 'mammographically occult'. The mask-
ing effect of radiologically dense parenchyma may account
for some cases, but a 'fatty' parenchymal pattern (Nl-P1)
Table n Distribution ofcases according to the review ofprevious screening mammograms and to other
studied variables
Classification ofprevious screening mammogran
Screening M'imnial signs Occult at
Total cases error present Occult diagnosis
(lOO%j (%) (%) (%) (%)
Total cases 134 16 (12) 35 (26) 73 (54) 10 (7)
Age (years)
40-49 27 3 (11) 6 (22) 13 (48) 5 (19)
50-59 42 6 (14) 12 (29) 21 (50) 3 (7)
60-69 65 7 (11) 17 (26) 39 (60) 2 (3)
Diagnostic modality
Screen detected 85 5 (6) 31 (36) 48 (56) 1 (1)
Interval 49 11 (22) 4 (8) 25 (51) 9 (18)
Tumour appearance on the
diagnostic mammogram"
Opacity, sharp 11 1 (9) 4 (36) 6 (54)
Opacity, undefined 55 11 (20) 13 (24) 31 (56)
Opacity, stellate 25 3 (12) 6 (24) 16 (64)
Calcifications 28 1 (3) 12 (43) 15 (54)
Distortion 2 2 (100)
Histological type
Intraductal 9 2 (22) 7 (78)
Ductal invasive 55 10 (18) 16 (29) 27 (49) 2 (4)
Lobular invasive 21 2 (9) 5 (24) 11 (52) 3 (14)
Other 49 4 (8) 12 (24) 28 (57) 5 (10)
Tumour size at diagnosisb (mm)
<10 33 2 (6) 8 (24) 23 (70)
11 -20 61 8 (13) 17 (28) 28 (46) 8 (13)
>20 30 6 (20) 8 (27) 15 (50) 1 (3)
Axillary nodesc
Involved 29 4 (13) 10 (34) 14 (48) 1 (3)
Not involved 93 11 (12) 22 (24) 52 (56) 8 (9)
Wolfe parenchymal pattern of
previous screening
mammogram 48 5 (10) 10 (21) 32 (67) 1 (2)
NI. P1 86 11 (19) 25 (29) 41 (48) 9 (10)
P2, Dy
aDiagnostic mammogram wasnotavailableinthreeinterval cases.bInvasivecasesonly; notavailable forone
interval case. clnvasive cases only; not determined for two cases.Brastcacerdekctabity by -ma wy
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was recorded in 44%/0 of cases. Fast tumour growth may be
another explanation for these cases. with cancers being under
the threshold of detectability at previous screening. Never-
theless. pT (pTis-pTla b = 41/% is 20%) and pN (pNO=
79% *s 73%) distribution was particularly favourable with
respect to other categories. whereas a less favourable stage
distribution might be expected for fast-growing tumours.
No abnormalitv was observed either on the previous
screening mammogram or on diagnosis in ten cases, mostly
(90%) interval cancers. Invasive lobular histological subtype.
which is known to be difficult to detect by mammography,
was observed in three cases. whereas a 'dense'. possibly
masking. P2-Dy parenchymal pattern was observed in nine of
ten cases.
Discussion
Apart from the v-ariability due to the limited sample size
considered. the results of the present study were strikingly
consistent with those reported by Van Dijck et al. (1993).
Screening error or minimal signs of tumour were observed at
the review of the previous screening mammograms in 31% of
interval cancers, but also in 42% of screen-detected cancers,
the latter figure being accounted for mostly by cases in the
minimal signs' category.
Screening errors might be reduced by improving the
quality of mammographic performance (especially as far as
positioning is concerned) and by reducing the chance of
misperception (e.g. double reading) but, according to our
results, this would achieve earlier diagnosis in at most 22%
of interval and 6% of screen-detected cancers.
Earlier detection of cancers showing minimal signs of
tumour at the review of the previous screening mammogram
would be much more promising, as 26% of all cancers were
classified in this category. Such a goal might be achieved by
adopting less stringent criteria for referral to diagnostic
assessment, especially for opacities with undefined margins
and isolated microcalcifications. Such a policy is just the
opposite to that currently adopted, aimed at improving
screening specificity, as shown by the low referral rate in
both the Florence and the Nijmegen Programmes (Ciatto et
al., 1990). At the repeat screening round in our programme
in the year 1992 the recall rate to assessment was 1.8%. the
benign biopsy rate was 0.07%. the benign malignant biopsy
ratio was 0.13: 1. the cancer detection rate was 0.51% and the
prevalence of invasive cancers <1 cm was 0.22% (0.24%
including pTIS). All these indicators suggest a high perfor-
mance, comparable to other European programmes (Wald et
al., 1993), and well within the range of the recommended
European standards (Kirkpatrick et al.. 1992). The majority
of cases which could be detected earlier by a more aggressive
diagnostic approach are in the 'minimal signs present'
category, that is they have a benign mammographic
appearance. Accepting less specific, benign mammographic
signs as positive would considerably increase referral and
biopsy rates, which might turn out to be unacceptable, as
suggested by Moskowitz (1983).
Reducing the rescreening interval to I year could be pro-
posed to decrease the interval cancer rate and to advance the
time of detection of some screen-detected cancers. However,
this would not be the case for interval cancers occurring in
the first year of the rescreening interval (22 of 49 in the
present study). or for interval or screen-detected cases which
were radiologically occult at diagnosis. As suggested by Van
Dijck et al. (1993), most screening errors would be diagnosed
at screening 1 year later. as well as an unknown proportion
of interval cancers of the second year and of screen-detected
cancers in the 'minimal signs present' and 'radiographically
occult' categories. In these cases the advance in detection
time with respect to biennial screening would be at most 1
year. and it is questionable whether this would have any
impact on further mortality reduction by screening, especially
considering the favourable stage distribution presently
observed in these subgroups (pTIS or invasive <1 cm =
77%, pNO = 75%). Moreover, reducing the rescreening inter-
val to 1 year almost doubles the cost compared with biennial
screening, and the benefit would certainly be inferior to that
obtained by investing equivalent resources to offer biennial
screening to more women. Although we agree that a careful
analysis of the cost-effectiveness of intensifying screening fre-
quency is worthwhile, such a policy should be discussed only
when the whole female population over 50 years old is
covered by a biennial screening programme, which presently
is not the case for the majority of European countries.
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